Hospitals in England have been urged to block the implementation of software developed by controversial tech firm Palantir by a coalition of patient, healthcare, worker, trade union, and consumer ...

Bristol Myers Squibb has brought one drug in the class to market – Opdualag, which combined LAG-3 drug relatlimab with PD-1 inhibitor nivolumab – but the company has subsequently been plagued by a ...

Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll. The Gallup/West Health survey (PDF) of around ...

The consequences of the US-Israel war in Iran have spilled over into the medtech sector, with a cyberattack launched against prominent US company Stryker. An Iranian hacker group has claimed ...

Chip giant NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius, a supplier to the life sciences industry and other sectors, focusing on the design and development of 'AI factories ...

Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

Ipsen has appointed biopharma industry veteran Michelle Werner to lead its North America business, as it pushes an ambitious growth strategy powered by intense dealmaking across oncology, rare ...

Eisai has launched a campaign to raise awareness of sleep disorders in Japan, via a partnership with smartphone app Pokémon ...

Artificial intelligence (AI) has high strategic importance within biopharma marketing, sales, and commercialisation and nearly six in 10 pharma leaders report seeing 2x ROI from AI initiatives within ...

Evotec has announced the next phase of its company overhaul, dubbed Horizon, that will see 800 people lose their jobs in a bid to cut €75 million in costs by the end of 2027. The layoffs follow around ...

Interim results from RAINIER reveal that an 80 mg dose of povetacicept every four weeks delivered a 52% reduction in protein ...

They are due to leave by the end of this year to set up an as-yet unnamed "independent biotechnology company to research and ...